NCT00667056

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 0.1% Tacrolimus Ointment in the Treatment of Chronic Allergic Contact Dermatitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 98 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 17 Years
• Healthy volunteers: Not accepted

Summary

A study of subjects with a known nickel allergy comparing Tacrolimus to placebo, both associated with nickel patches to determine the safety and efficacy of treating Chronic Allergic Contact Dermatitis with Tacrolimus Ointment

Conditions

• Dermatitis

Interventions

Type	Name	Description
DRUG	tacrolimus ointment	topical
DRUG	placebo ointment	topical

Timeline

• Start date: 2004-07-01
• Primary completion: 2004-12-01
• Completion: 2004-12-01
• First posted: 2008-04-25
• Last updated: 2014-09-18

Locations

10 sites across 1 country: United States